Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bosch

Showing results (931-940 of 1,009) with videos related to

Pageof 101
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2013
Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013C B Reusken, M Ababneh, V S Raj, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
Time to Viral Rebound After Interruption of Modern Antiretroviral TherapiesJonathan Z Li, Evgenia Aga, Ronald J Bosch, et al.
Cell Reports. Medicine|September 25, 2024
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIVTimothy J Henrich, Ronald J Bosch, Catherine Godfrey, et al.
Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2019
Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ARTRoger J Bedimo, Hanna Mar, Ronald J Bosch, et al.
AIDS (London, England)|October 22, 2019
T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapyBernard J C Macatangay, Rajesh T Gandhi, Richard B Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 9, 2024
The Association of Anemia With Survival Among People With HIV Following Antiretroviral Initiation in the NA-ACCORD 2007-2016Raynell Lang, Sally B Coburn, M John Gill, et al.
Clinical Science (London, England : 1979)|May 16, 2007
Effect of parathyroid-hormone-related protein on human platelet activationArantxa Ortega, Maria Teresa Pérez de Prada, Petra J Mateos-Cáceres, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 5, 2017
A Flow-Based Model of the HIV Care Continuum in the United StatesGregg S Gonsalves, A David Paltiel, Paul D Cleary, et al.
World Journal of Diabetes|September 4, 2023
New environmental factors related to diabetes risk in humans: Emerging bisphenols used in synthesis of plasticsRafael Moreno-Gómez-Toledano, María Delgado-Marín, Alberto Cook-Calvete, et al.
Pageof 101

Showing results (931-940 of 1,009) with videos related to

Sort By:
Pageof 101
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2013
Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013C B Reusken, M Ababneh, V S Raj, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
Time to Viral Rebound After Interruption of Modern Antiretroviral TherapiesJonathan Z Li, Evgenia Aga, Ronald J Bosch, et al.
Cell Reports. Medicine|September 25, 2024
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIVTimothy J Henrich, Ronald J Bosch, Catherine Godfrey, et al.
Plos Medicine|August 17, 2010
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialRajesh T Gandhi, Lu Zheng, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2019
Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ARTRoger J Bedimo, Hanna Mar, Ronald J Bosch, et al.
AIDS (London, England)|October 22, 2019
T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapyBernard J C Macatangay, Rajesh T Gandhi, Richard B Jones, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 9, 2024
The Association of Anemia With Survival Among People With HIV Following Antiretroviral Initiation in the NA-ACCORD 2007-2016Raynell Lang, Sally B Coburn, M John Gill, et al.
Clinical Science (London, England : 1979)|May 16, 2007
Effect of parathyroid-hormone-related protein on human platelet activationArantxa Ortega, Maria Teresa Pérez de Prada, Petra J Mateos-Cáceres, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 5, 2017
A Flow-Based Model of the HIV Care Continuum in the United StatesGregg S Gonsalves, A David Paltiel, Paul D Cleary, et al.
World Journal of Diabetes|September 4, 2023
New environmental factors related to diabetes risk in humans: Emerging bisphenols used in synthesis of plasticsRafael Moreno-Gómez-Toledano, María Delgado-Marín, Alberto Cook-Calvete, et al.
Pageof 101